Keywords : Antibody test
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 8, Pages 3509-3512
Introduction:By the end of December 2019, the outbreak of SARS COV 2 epidemic has occurred rapidly and has spread worldwide and was declared by WHO officially on March 11,2020 as a global pandemic. The global pandemic SARS COV 2 causing severe acute respiratory syndrome affecting the pregnant women has a limited number of case series. Only 10 cases are reported between 24 – 33+6 days with covid infection in literature with one normal delivery and 2 iatrogenic preterm deliveries. We report a case of covid 19 infection in second trimester and treated for hyperemesis gravidarum throughout pregnancy with good maternal and fetal outcome.
Case history:A 31-year-old G4P1L1A1 with previous LSCS was admitted thrice for hyperemesis gravidarum during first and second trimester. She was treated with IV fluids, antiemetics with electrolyte correction. At 29+3 weeks she was readmitted for hyperemesis gravidarum and tested positive for COVID 19 by RTPCR during screening. She was managed medically for hyperemesis gravidarum and advised home quarantine as she belonged to category B without hypoxia and asymptomatic. Emergency LSCS with sterilization was done at 38+3days in view of scar tenderness. Repeat RT PCR was negative and Antibody for SARS COV2 infection was Reactive (20.5 s/c). Mother and baby were discharged on Day 7.Conclusion: Pregnant women are not more likely to be severely unwell, need admission to intensive care or die from the illness than the non-pregnant women as per the current evidence even though vertical transmission might be possible